These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11422533)

  • 1. Azone enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis.
    Cato A; Swinehart JM; Griffin EI; Sutton L; Kaplan AS
    Int J Dermatol; 2001 Mar; 40(3):232-6. PubMed ID: 11422533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis.
    Schuttelaar ML; Coenraads PJ
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1076-82. PubMed ID: 18384552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis.
    Drake LA; Cohen L; Gillies R; Flood JG; Riordan AT; Phillips SB; Stiller MJ
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):209-14. PubMed ID: 10426891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: A randomized split-body control study.
    Cadmus SD; Sebastian KR; Warren D; Hovinga CA; Croce EA; Reveles LA; Levy ML; Diaz LZ
    Pediatr Dermatol; 2019 Jul; 36(4):437-441. PubMed ID: 30983001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
    Christiansen JV; Gadborg E; Kleiter I; Ludvigsen K; Meier CH; Norholm A; Reiter H; Reymann F; Raaschou-Nielsen W; Sondergaard M; Unna P; Wehnert R
    Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in selection of topical anti-inflammatory corticosteroids.
    Stewart WD; Runikis JO; Verma SC; Wallace S
    Can Med Assoc J; 1973 Jan; 108(1):33-8. PubMed ID: 4682636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
    Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
    Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive.
    Paller AS; Nimmagadda S; Schachner L; Mallory SB; Kahn T; Willis I; Eichenfield LF
    J Am Acad Dermatol; 2003 Apr; 48(4):569-77. PubMed ID: 12664021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial.
    Jensen JM; Weppner M; Dähnhardt-Pfeiffer S; Neumann C; Bräutigam M; Schwarz T; Fölster-Holst R; Proksch E
    Acta Derm Venereol; 2013 Sep; 93(5):515-9. PubMed ID: 23571785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experiences with hydrocortisone 17-butyrate.
    Yasuda T
    Dermatologica; 1976; 152 Suppl 1():221-9. PubMed ID: 782956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized investigator-blinded comparative study of moisturizer containing 4-t-butylcyclohexanol and licochalcone A versus 0.02% triamcinolone acetonide cream in facial dermatitis.
    Boonchai W; Varothai S; Winayanuwattikun W; Phaitoonvatanakij S; Chaweekulrat P; Kasemsarn P
    J Cosmet Dermatol; 2018 Dec; 17(6):1130-1135. PubMed ID: 29411520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluocinolone acetonide 0.01% in peanut oil: safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age.
    Dohil MA; Alvarez-Connelly E; Eichenfield LF
    Pediatr Dermatol; 2009; 26(3):262-8. PubMed ID: 19706085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of hydrocortisone valerate 0.2 percent ointment in the treatment of atopic dermatitis.
    Sefton J; Kyriakopoulos AA
    Cutis; 1983 Jul; 32(1):89-91, 94. PubMed ID: 6349943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis.
    Brunner PM; Khattri S; Garcet S; Finney R; Oliva M; Dutt R; Fuentes-Duculan J; Zheng X; Li X; Bonifacio KM; Kunjravia N; Coats I; Cueto I; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Jul; 138(1):169-178. PubMed ID: 26948076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Besnier's prurigo with Calmuril-hydrocortisone 1% cream and triamcinolone acetonide 0,1% cream. A controlled clinical study].
    Ludvigsen KE; Gadborg E
    Ugeskr Laeger; 1975 May; 137(19):1062-4. PubMed ID: 1094657
    [No Abstract]   [Full Text] [Related]  

  • 18. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%.
    Oldhoff JM; Knol EF; Laaper-Ertmann M; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Allergy; 2006 May; 61(5):622-8. PubMed ID: 16629794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose triamcinolone acetonide in the phytocosmetic lichtena reduces inflammation in mild to moderate atopic dermatitis.
    Pellanda C; Weber M; Bircher A; Surber C
    Dermatology; 2005; 211(4):338-40. PubMed ID: 16286743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.